Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Receptor-based assays in screening for biologically active substances.

I Shaw1

  • 1Xenova Ltd, Slough, UK.

Current Opinion in Biotechnology
|February 1, 1992
PubMed
Summary

New molecular targets like receptors and ligands are emerging for cancer and autoimmune diseases. Researchers use binding assays to find drug candidates, but data interpretation requires caution due to complex cellular signaling pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Food and exercise practices among British Pakistanis; how can Bourdieu's theory of practice help to understand them?

Perspectives in public health·2024
Same author

Corrigendum to <b>'Acid-base quantification: a review of developing technology'</b> [BJA Education 22 (2022) 440-7].

BJA education·2023
Same author

Corrigendum to '<b>Acid-base balance: a review of normal physiology</b>' [BJA Education 22 (2022) 396-401].

BJA education·2023
Same author

Acid-base quantification: a review of developing technology.

BJA education·2022
Same author

Acid-base balance: a review of normal physiology.

BJA education·2022
Same author

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

Medical teacher·2021

Area of Science:

  • Molecular biology
  • Pharmacology
  • Biochemistry

Background:

  • Receptors and ligands are key molecular players implicated in diseases like cancer and autoimmune conditions.
  • These molecules present promising targets for novel therapeutic strategies.
  • Recent advances enable high-throughput screening for drug discovery.

Purpose of the Study:

  • To highlight the potential of newly identified receptors and ligands as therapeutic targets.
  • To discuss the application of receptor-ligand binding assays in drug candidate screening.
  • To emphasize the need for careful data interpretation in assay development and application.

Main Methods:

  • Utilizing advanced instrumentation and methodologies for large-scale sample screening.
  • Employing simple receptor-ligand binding assays for drug candidate identification.
  • Characterizing novel receptors, including cytokine receptors.

Main Results:

  • Identification of deregulated receptors and ligands in disease states.
  • Feasibility of screening numerous samples using binding assays.
  • Emergence of potential drug candidates.

Conclusions:

  • Newly identified receptors and ligands offer rational targets for therapeutic intervention in cancer and autoimmune diseases.
  • Receptor-ligand binding assays are valuable tools for drug discovery.
  • Understanding the complex relationship between receptor signaling and disease states is crucial for accurate assay data interpretation, especially for newly characterized receptors like cytokine receptors.

Related Experiment Videos